AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - New Scientist UK Edition)
Within a few years the first vaccines designed to prevent cancer could be commercially available. However, great controversy could surround the decision on who should receive the vaccine and at what age. GlaxoSmithKline's (GSK's) vaccine against cervical cancer has just completed Phase II trials and the results indicate that it is 100% efficient in healthy young…